Search research articles
Contact Us
Filters
Showing results (91-100 of 102) with videos related to
Page
of 11
Sort By:
Haematologica
|
July 11, 2019
Effective hematopoietic stem cell-based gene therapy in a murine model of hereditary pulmonary alveolar proteinosis
Miriam Hetzel, Elena Lopez-Rodriguez, Adele Mucci, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 10, 2016
Sickle cell anemia mice develop a unique cardiomyopathy with restrictive physiology
Nihal Bakeer, Jeanne James, Swarnava Roy, et al.
Blood Advances
|
January 5, 2024
CRISPR/Cas9 deletion of MIR155HG in human T cells reduces incidence and severity of acute GVHD in a xenogeneic model
Lotus Neidemire-Colley, Shrijan Khanal, Kara M Braunreiter, et al.
The Journal of Clinical Investigation
|
December 23, 2015
Placenta growth factor augments airway hyperresponsiveness via leukotrienes and IL-13
Marthe-Sandrine Eiymo Mwa Mpollo, Eric B Brandt, Shiva Kumar Shanmukhappa, et al.
American Journal of Hematology
|
June 8, 2017
Losartan for the nephropathy of sickle cell anemia: A phase-2, multicenter trial
Charles T Quinn, Santosh L Saraf, Victor R Gordeuk, et al.
Human Gene Therapy
|
September 12, 2022
Preclinical Evaluation of Foamy Virus Vector-Mediated Gene Addition in Human Hematopoietic Stem/Progenitor Cells for Correction of Leukocyte Adhesion Deficiency Type 1
Richard H Smith, Hanan Bloomer, Danielle Fink, et al.
Stem Cell Reports
|
June 14, 2016
Integrated Genomic Analysis of Diverse Induced Pluripotent Stem Cells from the Progenitor Cell Biology Consortium
Nathan Salomonis, Phillip J Dexheimer, Larsson Omberg, et al.
Scientific Data
|
March 29, 2017
Molecular, phenotypic, and sample-associated data to describe pluripotent stem cell lines and derivatives
Kenneth Daily, Shannan J Ho Sui, Lynn M Schriml, et al.
Nature Medicine
|
May 26, 2025
Lentiviral gene therapy with reduced-intensity conditioning for sickle cell disease: a phase 1/2 trial
Michael Grimley, Stella M Davies, Archana Shrestha, et al.
Gene Therapy
|
September 8, 2021
Towards access for all: 1st Working Group Report for the Global Gene Therapy Initiative (GGTI)
Jennifer E Adair, Lindsay Androski, Lois Bayigga, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 102) with videos related to
Sort By:
Page
of 11
Haematologica
|
July 11, 2019
Effective hematopoietic stem cell-based gene therapy in a murine model of hereditary pulmonary alveolar proteinosis
Miriam Hetzel, Elena Lopez-Rodriguez, Adele Mucci, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 10, 2016
Sickle cell anemia mice develop a unique cardiomyopathy with restrictive physiology
Nihal Bakeer, Jeanne James, Swarnava Roy, et al.
Blood Advances
|
January 5, 2024
CRISPR/Cas9 deletion of MIR155HG in human T cells reduces incidence and severity of acute GVHD in a xenogeneic model
Lotus Neidemire-Colley, Shrijan Khanal, Kara M Braunreiter, et al.
The Journal of Clinical Investigation
|
December 23, 2015
Placenta growth factor augments airway hyperresponsiveness via leukotrienes and IL-13
Marthe-Sandrine Eiymo Mwa Mpollo, Eric B Brandt, Shiva Kumar Shanmukhappa, et al.
American Journal of Hematology
|
June 8, 2017
Losartan for the nephropathy of sickle cell anemia: A phase-2, multicenter trial
Charles T Quinn, Santosh L Saraf, Victor R Gordeuk, et al.
Human Gene Therapy
|
September 12, 2022
Preclinical Evaluation of Foamy Virus Vector-Mediated Gene Addition in Human Hematopoietic Stem/Progenitor Cells for Correction of Leukocyte Adhesion Deficiency Type 1
Richard H Smith, Hanan Bloomer, Danielle Fink, et al.
Stem Cell Reports
|
June 14, 2016
Integrated Genomic Analysis of Diverse Induced Pluripotent Stem Cells from the Progenitor Cell Biology Consortium
Nathan Salomonis, Phillip J Dexheimer, Larsson Omberg, et al.
Scientific Data
|
March 29, 2017
Molecular, phenotypic, and sample-associated data to describe pluripotent stem cell lines and derivatives
Kenneth Daily, Shannan J Ho Sui, Lynn M Schriml, et al.
Nature Medicine
|
May 26, 2025
Lentiviral gene therapy with reduced-intensity conditioning for sickle cell disease: a phase 1/2 trial
Michael Grimley, Stella M Davies, Archana Shrestha, et al.
Gene Therapy
|
September 8, 2021
Towards access for all: 1st Working Group Report for the Global Gene Therapy Initiative (GGTI)
Jennifer E Adair, Lindsay Androski, Lois Bayigga, et al.
Page
of 11